losartan – Page 3 – Communicable Diseases Research

Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review

Cardiovascular Medicine

Published on 2020-08-112022-10-31
Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19,

[키워드] 2019 novel coronavirus ACE2 ACE2 mRNA acute respiratory syndrome Angiotensin 1-7 bind cardiovascular damage cardiovascular diseases cardiovascular system caused cells clinical development clinical manifestation coronavirus COVID-19 develop disease downregulation drug epithelial cells expressed expression Heart damage host cell surface hydroxychloroquine/chloroquine interfere Local losartan lung lung alveolar mechanism modulate mRNA expression narrative pandemic Patient patients with COVID-19 pulmonary damage RAS RAS inhibitor RAS inhibitors reduced renin-angiotensin system respiratory symptoms responsible review SARS-CoV-2 System therapy Transmission umifenovir virulence virus
[DOI] 10.3389/fcvm.2020.00143 PMC 바로가기 [Article Type] Cardiovascular Medicine

Comorbidity Assessment Is Essential During COVID-19 Treatment

Physiology

Published on 2020-08-042022-10-31
Journal: Frontiers in Physiology [Category] COVID-19,

[키워드] ACE inhibitors affected Analysis assessment blockers cardiovascular disease cardiovascular diseases caused Comorbidities Comorbidity Coronavirus disease 2019 country COVID-19 death Deceased Deterioration determine diabete diabetes drug dysfunction endothelial Endothelium Essential European FIVE France Healthcare system heart disease hospital Hospitalized hospitalized patient hypertension immunodeficiency individuals Italy Kidney disease liver Liver disease losartan Lung diseases majority medications modulate Mortality Netherlands neurological outcome Patient proportion retrieved SARS-CoV2 severity significantly higher Spain t -test the disease Treatment with COVID-19
[DOI] 10.3389/fphys.2020.00984 PMC 바로가기 [Article Type] Physiology

Potential Treatment Options for COVID-19: A Comprehensive Review of Global Pharmacological Development Efforts

Internal Medicine

Published on 2020-06-262022-10-31
Journal: Cureus [Category] COVID-19,

The Network of Angiotensin Receptors in Breast Cancer

Review

Published on 2020-05-272022-10-31
Journal: Cells [Category] COVID-19,

A potential protective role of losartan against coronavirus-induced lung damage

Letter to the Editor

Published on 2020-03-172022-10-30
Journal: Infection Control and Hospital Epidemiology [Category] COVID-19, SARS,

[키워드] losartan lung damage protective role
[DOI] 10.1017/ice.2020.80 PMC 바로가기 [Article Type] Letter to the Editor

Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics

Article

Published on 2020-03-042023-06-14
Journal: Drug development research [Category] MERS, SARS,

[키워드] angiotensin‐converting enzyme 2 (ACE2) AT1R blockers COVID‐19 epidemic losartan SARS‐CoV‐2
[DOI] 10.1002/ddr.21656 PMC 바로가기

Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse

Letter to the Editor

Published on 2015-02-072023-05-31
Journal: Science China. Life sciences [Category] Fulltext, 조류인플루엔자,

[키워드] acute lung injury Avian Influenza H5N1 virus Influenza losartan
[DOI] 10.1007/s11427-015-4814-7 PMC 바로가기 [Article Type] Letter to the Editor